OBJECTIVE: Sudden unexplained death in epilepsy (SUDEP) during inpatient electroencephalography (EEG) monitoring has been a rare but potentially preventable event, with associated cardiopulmonary markers. To date, no systematic evaluation of alarm settings for a continuous pulse oximeter (SpO2 ) has been performed. In addition, evaluation of the interrelationship between the ictal and interictal states for cardiopulmonary measures has not been reported. METHODS: Patients with epilepsy were monitored using video-EEG, SpO2 , and electrocardiography (ECG). Alarm thresholds were tested systematically, balancing the number of false alarms with true seizure detections. Additional cardiopulmonary patterns were explored using automated ECG analysis software. RESULTS: One hundred ninety-three seizures (32 generalized) were evaluated from 45 patients (7,104 h recorded). Alarm thresholds of 80-86% SpO2 detected 63-73% of all generalized convulsions and 20-28% of all focal seizures (81-94% of generalized and 25-36% of focal seizures when considering only evaluable data). These same thresholds resulted in 25-146 min between false alarms. The sequential probability of ictal SpO2 revealed a potential common seizure termination pathway of desaturation. A statistical model of corrected QT intervals (QTc), heart rate (HR), and SpO2 revealed close cardiopulmonary coupling ictally. Joint probability maps of QTc and SpO2 demonstrated that many patients had baseline dysfunction in either cardiac, pulmonary, or both domains, and that ictally there was dissociation-some patients exhibited further dysfunction in one or both domains. SIGNIFICANCE: Optimal selection of continuous pulse oximetry thresholds involves a tradeoff between seizure detection accuracy and false alarm frequency. Alarming at 86% for patients that tend to have fewer false alarms and at 80% for those who have more, would likely result in a reasonable tradeoff. The cardiopulmonary findings may lead to SUDEP biomarkers and early seizure termination therapies. Wiley Periodicals, Inc.
OBJECTIVE:Sudden unexplained death in epilepsy (SUDEP) during inpatient electroencephalography (EEG) monitoring has been a rare but potentially preventable event, with associated cardiopulmonary markers. To date, no systematic evaluation of alarm settings for a continuous pulse oximeter (SpO2 ) has been performed. In addition, evaluation of the interrelationship between the ictal and interictal states for cardiopulmonary measures has not been reported. METHODS:Patients with epilepsy were monitored using video-EEG, SpO2 , and electrocardiography (ECG). Alarm thresholds were tested systematically, balancing the number of false alarms with true seizure detections. Additional cardiopulmonary patterns were explored using automated ECG analysis software. RESULTS: One hundred ninety-three seizures (32 generalized) were evaluated from 45 patients (7,104 h recorded). Alarm thresholds of 80-86% SpO2 detected 63-73% of all generalized convulsions and 20-28% of all focal seizures (81-94% of generalized and 25-36% of focal seizures when considering only evaluable data). These same thresholds resulted in 25-146 min between false alarms. The sequential probability of ictal SpO2 revealed a potential common seizure termination pathway of desaturation. A statistical model of corrected QT intervals (QTc), heart rate (HR), and SpO2 revealed close cardiopulmonary coupling ictally. Joint probability maps of QTc and SpO2 demonstrated that many patients had baseline dysfunction in either cardiac, pulmonary, or both domains, and that ictally there was dissociation-some patients exhibited further dysfunction in one or both domains. SIGNIFICANCE: Optimal selection of continuous pulse oximetry thresholds involves a tradeoff between seizure detection accuracy and false alarm frequency. Alarming at 86% for patients that tend to have fewer false alarms and at 80% for those who have more, would likely result in a reasonable tradeoff. The cardiopulmonary findings may lead to SUDEP biomarkers and early seizure termination therapies. Wiley Periodicals, Inc.
Authors: Brian K Gehlbach; Rup K Sainju; Deanne K Tadlock; Deidre N Dragon; Mark A Granner; George B Richerson Journal: Epilepsy Behav Date: 2018-06-30 Impact factor: 2.937
Authors: Elisa Bruno; Andrea Biondi; Sebastian Böttcher; Gergely Vértes; Richard Dobson; Amos Folarin; Yatharth Ranjan; Zulqarnain Rashid; Nikolay Manyakov; Aki Rintala; Inez Myin-Germeys; Sara Simblett; Til Wykes; Amanda Stoneman; Ann Little; Sarah Thorpe; Simon Lees; Andreas Schulze-Bonhage; Mark Richardson Journal: JMIR Res Protoc Date: 2020-12-16
Authors: Johan Arends; Roland D Thijs; Thea Gutter; Constantin Ungureanu; Pierre Cluitmans; Johannes Van Dijk; Judith van Andel; Francis Tan; Al de Weerd; Ben Vledder; Wytske Hofstra; Richard Lazeron; Ghislaine van Thiel; Kit C B Roes; Frans Leijten Journal: Neurology Date: 2018-10-24 Impact factor: 9.910
Authors: Anouk van Westrhenen; Thomas De Cooman; Richard H C Lazeron; Sabine Van Huffel; Roland D Thijs Journal: Clin Auton Res Date: 2018-10-30 Impact factor: 4.435
Authors: Sharon Shmuely; Rainer Surges; Robert M Helling; W Boudewijn Gunning; Eva H Brilstra; Judith S Verhoeven; J Helen Cross; Sanjay M Sisodiya; Hanno L Tan; Josemir W Sander; Roland D Thijs Journal: Ann Clin Transl Neurol Date: 2020-03-24 Impact factor: 4.511